Cargando…

Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding

Proline cis-trans isomerisation is a regulatory mechanism used in a range of biological processes, and is related to various diseases such as Alzheimers disease and cancer. However, the details of the exact molecular mechanism by which it occurs are not known. Using X-ray crystallography, proline is...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinoda, Keiko, Fujitani, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717248/
https://www.ncbi.nlm.nih.gov/pubmed/29208911
http://dx.doi.org/10.1038/s41598-017-16766-8
_version_ 1783284103805665280
author Shinoda, Keiko
Fujitani, Hideaki
author_facet Shinoda, Keiko
Fujitani, Hideaki
author_sort Shinoda, Keiko
collection PubMed
description Proline cis-trans isomerisation is a regulatory mechanism used in a range of biological processes, and is related to various diseases such as Alzheimers disease and cancer. However, the details of the exact molecular mechanism by which it occurs are not known. Using X-ray crystallography, proline isomerisation has been shown to occur following formation of an antigen-antibody complex between the target epiregulin (EPR) and the antibody 9E5, at proline (Pro103), located in the third complementarity-determining region (CDR) of the heavy chain of 9E5. To obtain an accurate description of the pathway involved in cis-trans isomerisation in this system, we performed ten independent long molecular dynamics (MD) simulations starting at a stable transient bound structure obtained from many short binding MD simulations. As a result, we were able to describe the process by which cis-trans isomerisation is initiated, and suggest a catalysis mechanism for cis-trans isomerization in this antigen-antibody system. We found that Asp102, which is immediately adjacent to Pro103, rotates while changing its interacting partner residues in the light chain of 9E5, and at the same time EPR polar residues help to stabilise the intermediate states in the isomerisation process by interacting strongly with Asp102.
format Online
Article
Text
id pubmed-5717248
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57172482017-12-08 Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding Shinoda, Keiko Fujitani, Hideaki Sci Rep Article Proline cis-trans isomerisation is a regulatory mechanism used in a range of biological processes, and is related to various diseases such as Alzheimers disease and cancer. However, the details of the exact molecular mechanism by which it occurs are not known. Using X-ray crystallography, proline isomerisation has been shown to occur following formation of an antigen-antibody complex between the target epiregulin (EPR) and the antibody 9E5, at proline (Pro103), located in the third complementarity-determining region (CDR) of the heavy chain of 9E5. To obtain an accurate description of the pathway involved in cis-trans isomerisation in this system, we performed ten independent long molecular dynamics (MD) simulations starting at a stable transient bound structure obtained from many short binding MD simulations. As a result, we were able to describe the process by which cis-trans isomerisation is initiated, and suggest a catalysis mechanism for cis-trans isomerization in this antigen-antibody system. We found that Asp102, which is immediately adjacent to Pro103, rotates while changing its interacting partner residues in the light chain of 9E5, and at the same time EPR polar residues help to stabilise the intermediate states in the isomerisation process by interacting strongly with Asp102. Nature Publishing Group UK 2017-12-05 /pmc/articles/PMC5717248/ /pubmed/29208911 http://dx.doi.org/10.1038/s41598-017-16766-8 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Shinoda, Keiko
Fujitani, Hideaki
Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding
title Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding
title_full Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding
title_fullStr Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding
title_full_unstemmed Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding
title_short Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding
title_sort initiation of prolyl cis-trans isomerisation in the cdr-h3 loop of an antibody in response to antigen binding
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717248/
https://www.ncbi.nlm.nih.gov/pubmed/29208911
http://dx.doi.org/10.1038/s41598-017-16766-8
work_keys_str_mv AT shinodakeiko initiationofprolylcistransisomerisationinthecdrh3loopofanantibodyinresponsetoantigenbinding
AT fujitanihideaki initiationofprolylcistransisomerisationinthecdrh3loopofanantibodyinresponsetoantigenbinding